Works matching IS 20457634 AND DT 2020 AND VI 9 AND IP 14


Results: 37
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Sorafenib and everolimus in patients with advanced solid tumors and KRAS‐mutated NSCLC: A phase I trial with early pharmacodynamic FDG‐PET assessment.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 14, p. 4991, doi. 10.1002/cam4.3131
    By:
    • Nogova, Lucia;
    • Mattonet, Christian;
    • Scheffler, Matthias;
    • Taubert, Max;
    • Gardizi, Masyar;
    • Sos, Martin L.;
    • Michels, Sebastian;
    • Fischer, Rieke N.;
    • Limburg, Meike;
    • Abdulla, Diana S.Y.;
    • Persigehl, Thorsten;
    • Kobe, Carsten;
    • Merkelbach‐Bruse, Sabine;
    • Franklin, Jeremy;
    • Backes, Heiko;
    • Schnell, Roland;
    • Behringer, Dirk;
    • Kaminsky, Britta;
    • Eichstaedt, Martina;
    • Stelzer, Christoph
    Publication type:
    Article
    18
    19
    20
    21
    22

    Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3‐day aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study

    Published in:
    Cancer Medicine, 2020, v. 9, n. 14, p. 5134, doi. 10.1002/cam4.3123
    By:
    • Chang, Jianhua;
    • Chen, Gongyan;
    • Wang, Dong;
    • Wang, Guihua;
    • Lu, Shun;
    • Feng, Jifeng;
    • Li, Wei;
    • Li, Ping;
    • Lanzarotti, Corinna;
    • Chessari, Salvatore;
    • Zhang, Li
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Issue Information.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 14, p. 4879, doi. 10.1002/cam4.2300
    Publication type:
    Article